65,437 trials
Diabetes Mellitus
Primary: Rate of Primary Lung Cancer Mortality — 0.48; 0.17 Deaths per 1000 patient years (PY)
Metabolic Syndrome
Primary: Marker of Fibrinolysis — 10.5; 12.3 ng/mL
Nephrolithiasis · Urolithiasis · Idiopathic Hypercalciuria
Primary: Change in 24 Hour Urine Calcium — 2 mg/day
Acne Vulgaris
Primary: Erythema (Redness) — 0.66; 0.91; 0.55; 0.74 units on a scale
Overactive Bladder
Primary: Evaluate Subjective Patient Change in Irritative Urinary Symptoms as Measured by the Overactive Bladder Questionnaire (OAB-q) Symptom Bother Score — 65.4; 61.6; 46.7…
HIV · HIV Infections
Primary: The Percentage of Participants With HIV-1 Ribonucleic Acid (RNA) Less Than 50 Copies/mL at Week 24 — 89.6; 87.0 percentage of participants
Schizophrenia
Primary: The Proportion of Patients Improving 20% in Total Positive and Negative Syndrome Scale (PANSS) at Endpoint (Day 90) — 97.73 percentage of patients
HIV · HIV Infections
Primary: The Percentage of Participants With Virologic Success Using the Food and Drug Administration (FDA)-Defined Snapshot Analysis as Determined by the Achievement of HIV-1…
DCIS
Primary: Local Control Rate for Follow-up Period of 5 Years. — 99 percentage of subjects
Diabetes
Primary: Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/- 15mg/dL (<75 mg/dL) or Within +/- 20% (>=75 mg/dL) of Laboratory Glucose Method — 115 BG test results
HIV · HIV Infections
Primary: The Percentage of Participants With Virologic Success Using the Food and Drug Administration (FDA)-Defined Snapshot Analysis as Determined by the Achievement of HIV-1…
Hypertension
Primary: Reduction From the Reference Baseline in Mean Seated Diastolic Blood Pressure (DBP) at Trough — 4.93; 3.47 mm Hg
Chronic Hepatitis C
Primary: Cmax (Maximum Observed Concentration in Plasma) of MP-424 — 2.24; 3.34; 3.68 μg / mL
Bullous Pemphigoid
Primary: Primary Safety Endpoint — 0; 0; 1 participants
Hypertension · Chronic Kidney Disease
Primary: The Change of Blood Pressure — -22.7; -5 mmHg